GlassScriptPhysician profile
Kaitlin Kim
NPI 1790314102
$1,100.72
in general payments reported to CMS, 2019-2025
27 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23.22 · 2023: $549 · 2024: $353 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,077.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $306.92 | 2023-2025 | |
| Abbvie INC. | $88.47 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $81.48 | 2023-2024 | Libtayo |
| Bayer Healthcare Pharmaceuticals INC. | $52.29 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $48.52 | 2022-2023 | Ultomiris |
| Merck Sharp & Dohme LLC | $43.41 | 2023-2024 | Keytruda |
| Medtronic, INC. | $38.10 | 2024 | Ligasure, Valleylab Ft10 |
| Kerecis Limited | $28.74 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Tempus Ai, INC | $28.14 | 2024 | Xt Cdx |
| C. R. Bard, INC. & Subsidiaries | $27.29 | 2023 | Arista Ah Flexitip |
| Janssen Biotech, INC. | $25.99 | 2023 | Darzalex, Tecvayli |
| Ethicon US, LLC | $25.27 | 2024 | Enseal |
| Morphosys, US INC. | $24.81 | 2023 | Monjuvi |
| Takeda Pharmaceuticals U.S.A., INC. | $23.58 | 2023 | |
| Mirati Therapeutics, INC. | $23.01 | 2023 | Krazati |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medicine, INC. | $22.96 | 2023 | Foundationone Cdx |
| Angiodynamics, INC. | $22.51 | 2025 | Smart Port Ct |
| Immunogen, INC. | $22.51 | 2023 | Elahere |
| Lilly USA, LLC | $22.29 | 2023 | Jaypirca, Verzenio |
| E.R. Squibb & Sons, L.L.C. | $21.91 | 2024 | Opdivo |
| Pharmaessentia USA Corporation | $20.61 | 2025 | Besremi |
| Genentech USA, INC. | $19.86 | 2023 | Venclexta |
| Alnylam Pharmaceuticals INC. | $19.31 | 2023 | Givlaari |
| Incyte Corporation | $18.31 | 2023 | Jakafi |
| Exelixis INC. | $17.03 | 2023 | Cabometyx |
| Hologic Sales and Service, LLC | $14.42 | 2024 | Coolseal Generator |
| Novartis Pharmaceuticals Corporation | $12.98 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.